| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.37 | 0.03 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.25 | 0.03 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.36 | 0.03 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |